Oral SARS‐CoV‐2 Infection and Risk for Long Covid
Joel Schwartz,
No information about this author
Kristelle J. Capistrano,
No information about this author
Heba Hussein
No information about this author
et al.
Reviews in Medical Virology,
Journal Year:
2025,
Volume and Issue:
35(2)
Published: March 1, 2025
ABSTRACT
SARS‐CoV‐2
is
an
oral
pathogen
that
infects
and
replicates
in
mucosal
salivary
epithelial
cells,
contributing
to
post‐acute
sequelae
COVID‐19
(PASC)
other
non‐oral
pathologies.
While
pre‐existing
inflammatory
diseases
provides
a
conducive
environment
for
the
virus,
acute
infection
persistence
of
can
also
results
microbiome
dysbiosis
further
worsens
poor
health.
Indeed,
PASC
includes
periodontal
diseases,
dysgeusia,
xerostomia,
pharyngitis,
keratoses,
pulpitis
suggesting
significant
bacterial
contributions
tissue
tropism.
Dysbiotic
microbiome‐induced
inflammation
promote
viral
entry
via
angiotensin‐converting
enzyme
receptor‐2
(ACE2),
serine
transmembrane
TMPRSS2
possibly
non‐canonical
pathways.
Additionally,
metabolites
derived
from
dysbiotic
alter
physiological
biochemical
pathways
related
metabolism
lipids,
carbohydrates,
amino
acids.
This
may
pro‐inflammatory
microenvironment,
leading
immune
exhaustion,
loss
tolerance,
susceptibility
variety
pathogens,
causing
later
chronic
inflammation.
Microbial
release
mimics
host
metallopeptidases
furin,
ADAM17
(A
disintegrin
metalloproteinase
17),
glycoprotein
aid
attachment
T
cell
immunoglobulin‐like
(TIMs),
enhancing
while
simultaneously
depressing
resistance
clearance.
Membrane
reorganization
characterised
by
neuroproteins,
such
as
neuropilins,
functionally
assists
with
extends
pathogenesis
cavity
brain,
gut,
or
tissues.
Thus,
health,
disrupted
microbiomes
tropism,
weaken
antiviral
resistance,
heightens
infection.
dysfunction
increases
risk
additional
infections,
exacerbating
conditions
like
endodontic
diseases.
These
persistent
health
issues
contribute
systemic
inflammation,
creating
bidirectional
effects
between
tissues,
potentially
Post‐Acute
Sequelae
(PASC).
Language: Английский
Decoding the intricacies: a comprehensive analysis of microRNAs in the pathogenesis, diagnosis, prognosis and therapeutic strategies for COVID-19
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Oct. 7, 2024
The
pandemic
of
coronavirus
disease-19
(COVID-19),
provoked
by
the
appearance
a
novel
named
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2),
required
worldwide
healthcare
emergency.
This
has
elicited
an
immediate
need
for
accelerated
research
into
its
mechanisms
disease,
criteria
diagnosis,
methods
forecasting
outcomes,
and
treatment
approaches.
microRNAs
(miRNAs),
are
diminutive
RNA
molecules,
that
non-coding
participate
in
gene
expression
regulation
post-transcriptionally,
having
important
participation
regulating
immune
processes.
miRNAs
have
granted
substantial
interest
their
impact
on
viral
replication,
cell
proliferation,
modulation
how
host’s
system
responds.
narrative
review
delves
host
miRNAs’
multifaceted
roles
within
COVID-19
context,
highlighting
involvement
disease
progression,
diagnostics,
prognostics
aspects,
given
stability
biological
fluids
varied
profiles
when
responding
to
infection.
Additionally,
we
discuss
complicated
interactions
between
SARS-CoV-2
cellular
machinery
facilitated
revealing
dysregulation
miRNA
advances
evasion,
inflammatory
responses.
Furthermore,
it
investigates
potential
as
therapeutic
agents,
whether
synthetic
or
naturally
occurring,
which
could
be
harnessed
either
mitigate
harmful
inflammation
enhance
antiviral
However,
searching
more
deeply
is
needed
clarify
involved
pathogenesis
COVID-19,
diagnosis
processes,
prognostic
assessments,
approaches
patients.
Language: Английский
Endogenous miRNA-Based Innate-Immunity against SARS-CoV-2 Invasion of the Brain
Walter J. Lukiw,
No information about this author
Aileen I. Pogue
No information about this author
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(4), P. 3363 - 3363
Published: Feb. 8, 2023
The
severe
acute
respiratory
syndrome
Coronavirus-2
(SARS-CoV-2),
the
causative
agent
of
COVID-19,
possesses
an
unusually
large
positive-sense,
single-stranded
viral
RNA
(ssvRNA)
genome
about
~29,903
nucleotides
(nt).
In
many
respects,
this
ssvRNA
resembles
a
very
large,
polycistronic
messenger
(mRNA)
possessing
5′-methyl
cap
(m7GpppN),
3′-
and
5′-untranslated
region
(3′-UTR,
5′-UTR),
poly-adenylated
(poly-A+)
tail.
As
such,
SARS-CoV-2
is
susceptible
to
targeting
by
small
non-coding
(sncRNA)
and/or
microRNA
(miRNA),
as
well
neutralization
inhibition
its
infectivity
via
human
body’s
natural
complement
~2650
miRNA
species.
Depending
on
host
cell
tissue
type,
in
silico
analysis,
sequencing,
molecular-genetic
investigations
indicate
that,
remarkably,
almost
every
single
has
potential
interact
with
primary
sequence
ssvRNA.
Individual
variation
abundance,
speciation,
complexity
among
different
populations
additional
variability
distribution
angiotensin
converting
enzyme-2
(ACE2)
receptor
(ACE2R)
appear
further
contribute
basis
for
wide
individual
susceptibility
COVID-19
infection.
paper,
we
review
recently
described
aspects
ribonucleotide
structure
highly
evolved
miRNA–ssvRNA
recognition
signaling
system
and,
first
time,
report
most
abundant
miRNAs
control
superior
temporal
lobe
neocortex
(STLN),
anatomical
area
involved
cognition
targeted
both
invasion
Alzheimer’s
disease
(AD).
We
evaluate
important
factors
involving
neurotropic
nature
ACE2R
STLN
that
modulate
significant
functional
deficits
brain
CNS
associated
infection
COVID-19’s
long-term
neurological
effects.
Language: Английский
Circulatory microRNAs as potential biomarkers for different aspects of COVID-19
Archives of Virology,
Journal Year:
2024,
Volume and Issue:
170(1)
Published: Dec. 12, 2024
Language: Английский
The signature of SARS-CoV-2 evolution reflects selective pressures within human guts
Ancha Baranova,
No information about this author
A. Zhiyanov,
No information about this author
M. Shkurnikov
No information about this author
et al.
Authorea (Authorea),
Journal Year:
2023,
Volume and Issue:
unknown
Published: April 7, 2023
In
somatic
cells,
microRNAs
(miRNAs)
bind
to
the
genomes
of
RNA
viruses
and
influence
their
translation
replication.
Here
we
demonstrate
that
a
significant
number
miRNA
binding
sites
locate
in
NSP4
region
SARS-CoV-2
genome,
intestinal
human
miRNAs
exert
evolutionary
pressure
on
this
region.
Notably,
infected
promotes
formation
double-membrane
vesicles,
which
serve
as
scaffolds
for
replication-transcriptional
complexes
protect
viral
from
intracellular
destruction.
three
years
selection,
loss
many
sites,
particular,
those
within
NSP4,
has
shaped
promote
descendants
BA.2
variants
dominant
strains
define
current
momentum
pandemics.
Findings
highlight
possibility
tissue
may
significantly
impact
evolution
genome
play
pivotal
role
long
COVID.
Language: Английский
The signature of SARS‐CoV‐2 evolution reflects selective pressures within human guts
Journal of Medical Virology,
Journal Year:
2023,
Volume and Issue:
95(8)
Published: July 29, 2023
Abstract
In
somatic
cells,
microRNAs
(miRNAs)
bind
to
the
genomes
of
RNA
viruses
and
influence
their
translation
replication.
London
Berlin
samples
represented
in
GISAID
database,
we
traced
severe
acute
respiratory
syndrome
coronavirus
2
(SARS‐CoV‐2)
lineages
divided
these
sequenced
two
groups,
“Ancestral
variants”
“Omicrons,”
analyzed
them
through
prism
tissue‐specific
binding
between
host
miRNAs
viral
messenger
RNAs.
We
demonstrate
a
significant
number
miRNA‐binding
sites
NSP4
region
SARS‐CoV‐2
genome,
with
evidence
evolutionary
pressure
within
this
exerted
by
human
intestinal
miRNAs.
Notably,
infected
promotes
formation
double‐membrane
vesicles,
which
serve
as
scaffolds
for
replication‐transcriptional
complexes
protect
from
intracellular
destruction.
3
years
selection,
loss
many
general
those
particular
has
shaped
genomes.
With
that,
descendants
BA.2
variants
were
promoted
dominant
strains,
define
current
momentum
pandemics.
Language: Английский